Viewing Study NCT00144768


Ignite Creation Date: 2025-12-24 @ 5:29 PM
Ignite Modification Date: 2025-12-25 @ 3:03 PM
Study NCT ID: NCT00144768
Status: COMPLETED
Last Update Posted: 2014-05-05
First Post: 2005-09-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
Sponsor: Genzyme, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-07
Start Date Type: None
Primary Completion Date: 2007-05
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2005-09-02
First Submit QC Date: None
Study First Post Date: 2005-09-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-02
Last Update Post Date: 2014-05-05
Last Update Post Date Type: ESTIMATED